Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

End-stage Renal Disease

Interventions

DRUG

sodium bicarbonate 500mg capsules

Defined by active substance and brand names not specified in protocol

Trial Locations (1)

Imperial College Healthcare NHS Trust, London

All Listed Sponsors

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Imperial College Healthcare NHS Trust

OTHER

NCT02692378 - Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD) | Biotech Hunter | Biotech Hunter